Neugenesis Corporation
Biomedicines for the 21st Century
Neugenesis has developed new technology for rapid, inexpensive discovery and production of high value biopharmaceuticals.
The company has created proprietary platforms which provide:
- Better ways to produce complex biologics including
- multivalent vaccines
- monoclonal antibodies
- and new ways to improve these products using
- directed evolution, and
- combinatorial biology
Neugenesis' proprietary technologies result from the ability to leverage fundamental biological research into commercial biotechnology applications.
